Patient with rare lung cancer faces legal battle to obtain R$ 30,000 medication
A 32-year-old resident of Presidente Prudente, Brazil, diagnosed with a rare form of lung cancer, is fighting a legal battle for access to a costly medication that could enhance her treatment.
The end of the best-selling prescription medication causes pain - 'Outrageous price'
The shortage of the widely-used anticoagulant apixaban in Finland has led to significant distress due to skyrocketing prices and limited access, caused by a patent dispute among pharmaceutical companies.
Threatened prison guard - blames low blood sugar
A convicted man threatened a prison guard after being denied immediate access to medication, claiming low blood sugar caused his behavior.
Anna Bratt: Who Should Have Access to New, Expensive Weight Loss Medications?
The recent denial of a subsidy for the weight loss medication Wegovy raises questions about who can afford access to such costly treatments.
Ana Paula and Chaiany from BBB 26 discuss access to Roacutan in SUS; learn how it works
Ana Paula and Chaiany from Big Brother Brazil 26 discussed the access to Roacutan, a medication for treating severe acne, through Brazil's public health system (SUS).
Let the death row inmates have hope.
A 62-year-old ALS patient in Norway describes her struggle to access life-prolonging medication after being denied participation in clinical trials and treatment options, highlighting the paradox of medical regulations.
Inmates in Danish Prisons Protest for Better Conditions
Inmates across several Danish prisons staged a protest demanding improved living conditions, citing issues like medication access and delayed responses to their medical needs.
White House unveils TrumpRx website for medication discounts
The White House launched TrumpRx.gov, a platform for consumers to access discounts on certain brand-name medications when paying cash, featuring 43 drugs from five pharmaceutical companies.
Idec criticizes new drug pricing rules and says medicines could become more expensive
Idec expresses concerns that Brazil's new drug pricing regulations, effective from April, may not address fundamental issues in pricing policy and could further restrict access to medications.